Tackling EGFR signaling with TACE antagonists: a rational target for metalloprotease inhibitors in cancer

By Kenny Paraic A  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 10, 2007-10 ,pp. : 1287-1298

Informa Healthcare

Access to resources Recommend Favorite

Dual inhibition of MEK1/2 and EGFR synergistically induces caspase-3-dependent apoptosis in EGFR inhibitor-resistant lung cancer cells via BIM upregulation

By Song Ji-Young   Kim Choung-Soo   Lee Je-Hwan   Jang Se   Lee Sang-wook   Hwang Jung   Lim Chulsoo   Lee Gilnam   Seo Jeongbeob   Cho Suk   Choi Jene  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1458-1465

Springer Publishing Company

Access to resources Recommend Favorite

Src Family Kinases: Potential Targets for the Treatment of Human Cancer and Leukemia

By  

Current Pharmaceutical Design, Vol. 9, Iss. 25, 2003-10 ,pp. : 2043-2059

Bentham Science Publishers

Access to resources Recommend Favorite

Growth Factor Signaling and Resistance to Cancer Chemotherapy

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 13, 2004-09 ,pp. : 1345-1354

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Combination of Targeted Therapies As A Strategy to Overcome The Mechanisms of Resistance to Inhibitors of EGFR Signaling

By  

Current Pharmaceutical Design, Vol. 13, Iss. 33, 2007-11 ,pp. : 3358-3367

Bentham Science Publishers

Access to resources Recommend Favorite